News

A new phase 3 trial (INTERLACE) shows that adding induction chemotherapy to standard chemoradiotherapy improves both progression-free and overall survival in patients with locally advanced cervical cancer.

Novel research has challenged conventional thinking around microbial associations with diseases like inflammatory bowel disease and colorectal cancer.

Findings indicated that patients taking ARBs had a higher likelihood of experiencing persistent symptoms and markers of poor small bowel healing.

The findings suggest that healthcare systems must prioritise post-COVID-19 care, with a focus on identifying and managing autoimmune and autoinflammatory disorders.

Machine learning identifies key factors and predicts success in renal replacement therapy discontinuation for critically ill patients with acute kidney injury.

Recent data shows a significant increase in germline genetic testing for prostate cancer, with a notable rise in urologist involvement.

No difference in mortality found between indwelling pleural catheters and chemical pleurodesis for treating malignant pleural effusions.

VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study.